Resmed Inc ( (RMD) ) has released its Q1 earnings. Here is a breakdown of the information Resmed Inc presented to its investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Resmed Inc., a leader in digital health solutions and cloud-connected devices, focuses on enhancing sleep and breathing health through innovative technologies. The company reported a strong start to fiscal year 2026 with a 9% increase in revenue, reaching $1.3 billion, and a significant improvement in gross margin. Key financial highlights include a 15% increase in income from operations and a 16% rise in non-GAAP diluted earnings per share, driven by robust sales growth and improved manufacturing efficiencies. Resmed’s strategic investments in innovation and operational excellence have contributed to these positive results. Looking ahead, Resmed remains committed to delivering sustainable growth by expanding access to its healthcare solutions worldwide, as evidenced by its recent initiatives and board changes.

